Pegilodecakin plus anti-PD-1 showed tolerability and efficacy in some advanced solid tumors. Click to show full abstract
Pegilodecakin plus anti-PD-1 showed tolerability and efficacy in some advanced solid tumors.
               
Click one of the above tabs to view related content.